Supporting Women in the Business World

Supporting Women in the Business World

We provide women with education, information and networking opportunities through a program of events conducted across the Shoalhaven area at local restaurants and wineries, enjoyed over lunch.

Wednesday, 19 September 2012

October is EnGeneIC Month


St. George Regional Business Bank

Women in Business EnGeneIC Luncheon

Guest Speaker
Dr Jennifer MacDiarmid PhD
Joint Managing Director - EnGeneIC

Managing My Busy Life..…..
Wednesday 10th October, 2012
at
The Butterfactory Restaurant
739 Greenwell Point Road, Pyree

October is normally our PINK lunch which is about raising funds for a very worthy charity the Cancer Council, however this year we are changing our charity to EnGeneIC.

EnGeneIC’s mission is to change the perception of cancer from life threatening to curable. They aim to revolutionise the treatment of cancer through the targeted delivery of therapeutic-agents directly to cancer cells. The proprietary EnGeneIC Delivery Vehicle (EDV) can be used as a platform for the creation of tailor-made cancer therapies, dramatically minimising the side effects commonly associated with chemotherapy and improving outcomes for patients.

EnGeneIC is a totally owned Australian Company, looking for funding to continue its research, so please join us to help this company from being taken over by an overseas pharmaceutical company and keep it in Australia.

Dr MacDiarmid and Joint Managing Director Dr Himanshu Brahmbhatt have featured on Australian Story twice and have a remarkable story to tell.


Jennifer is the founder & Managing Director of EnGeneIC Ltd where together with Dr Himanshu Brahmbhatt, she has developed minicells, derived from bacteria, with special properties which allow them to be packed with both conventional anti-cancer drugs and a relatively new anti-cancer therapeutic called small interfering RNA (siRNA).

Both Jennifer and Himanshu have also set up the EnGeneIC Cancer Research Foundation. This foundation is committed to supporting Australian research in developing targeted cancer treatments, particularly funding patients into clinical trials and for rare tumours. The foundation also supports young Australian scientists through scholarships to complete a PhD program or post-doctoral studies.